International Journal of Clinical Research

Objective To investigate the actual efficacy of levocetirizine oral solution combined with doxycycline tablets in the treatment of children with mycoplasma pneumonia and its specific effects on the improvement of symptoms and inflammatory markers in children. Methods Eighty children with mycasma pneumonia who were treated in our hospital from July 2023 to December 2024 were selected as the research objects. They were divided into two groups random number table method. The experimental group of 40 children received levocetirizine oral solution combined with doxycycline tablets, and the control group of 4 children received doxycycline tablets alone. The total effective rate of treatment, the time of symptom relief, the level of inflammatory markers and the incidence of adverse reactions were compared between two groups. Results The total effective rate of treatment in children of the experimental group was significantly higher than that of the control group. The time of symptom relief such as cough, and rales in the lungs was shorter than that of the control group. The levels of two inflammatory markers, serum C-reactive protein and white blood cell count, were lower those of the control group. There were significant differences between the two groups (P < 0.05). There was no significant difference in adverse reactions between the two groups (P > 0.05). Conclusion Levocetirizine oral solution combined with doxycycline tablets is very effective in the treatment of children with mycoplasma pneumonia. It can effectively improve the curative effect, accelerate the remission of symptoms in, reduce the inflammatory response, and has very high application value in the clinical treatment of children with mycoplasma pneumonia.

Levocetirizine oral solution; Doxycycline tablets; Mycoplasma pneumonia; Children; Treatment efficacy